Clinical Trials on 骨髄抑制療法を受けている固形腫瘍患者 in Canada
合計1件
-
Pfizer終了しましたタラゾパリブと組み合わせたアベルマブは、局所進行性（原発性または再発性）または転移性固形腫瘍の患者で調査されますアメリカ, カナダ, イギリス, 大韓民国, オーストラリア, ベルギー, デンマーク, ハンガリー, ロシア連邦
このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。
スポンサーと協力者
- Fonden for Faglig Udvikling af Speciallægepraksis
- Avextra Pharma GmbH
- Tartu Health Care College
- Emilia Bagiella
- World in Harmony/Mundo en Armonia
- University of Toyama
- Fehmi Tabak
- Viviane de Souza Pinho Costa
- Tsinghua University
- Mario Ammirati
- Prolacta Bioscience
- Kristine Patterson, MD
- Chan Zuckerberg Initiative Grant
- OOO MNPK BIOTIKI
- Department of Clinical Immunology, Odense University Hospital
- Dean Foundation
- Rowe, Veronica, M.D.
- Bayi Children's Hospital Affiliated to Beijing Military Gen Hospital
- Affiliated Hospital to Academy of Military Medical Sciences
- Brain Injury Association of Pennsylvania
- 全リストを表示
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Canada
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Denmark
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Gambia
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Malawi
- Contract Research Organizations in Poland
- Contract Research Organizations in Ukraine
- Contract Research Organizations in United Arab Emirates
- CRO list by country